Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Prostate Cancer Treatment and Research, Estrogen and related hormone effects, Cancer, Hypoxia, and Metabolism, and Hormonal and reproductive studies.
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
Inhibition of the serine/threonine kinase BUB1 reverses taxane resistance in prostate cancer
Inhibition of the serine/threonine kinase BUB1 reverses taxane resistance in prostate cancer
Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens.
Data from Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans
Supplementary Figure from Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans
Supplementary Figure from Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans
Data from Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans
The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor
The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor.
Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans.
Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.
Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer
Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
Targeting AR Variant–Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities
The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related
Essential Components of Cancer Education
Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer
VAV3 mediates resistance to breast cancer endocrine therapy
Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells
Targeting IGF-IR with Ganitumab Inhibits Tumorigenesis and Increases Durability of Response to Androgen-Deprivation Therapy in VCaP Prostate Cancer Xenografts
Novel Interaction between the Co-chaperone Cdc37 and Rho GTPase Exchange Factor Vav3 Promotes Androgen Receptor Activity and Prostate Cancer Growth*
The microRNA -23b/-27b Cluster Suppresses the Metastatic Phenotype of Castration-Resistant Prostate Cancer Cells
Vav3 Enhances Androgen Receptor Splice Variant Activity and Is Critical for Castration-Resistant Prostate Cancer Growth and Survival
In Vivo 17β-Estradiol Treatment Contributes to Podocyte Actin Stabilization in Female db/db Mice